Levels of ADAMTS13, an antithrombotic metalloprotease which cleaves highly adhesive large von Willebrand factor (VWF) multimers after their release from activated endothelium [18], decreased significantly with increasing COVID-19 severity (Fig. 2g). This evidence concerns the gene VWF and COVID-19.